(BPT) - In the relentless battle against Alzheimer's disease, researchers are looking closely at a lab-made version of thiamine (also known as vitamin B1). This nutrient, crucial for brain function and energy production, is now in the spotlight for its potential role in combating cognitive decline.

Alzheimer's disease is a progressive disease that causes problems with memory, thinking and behavior that affects nearly seven million individuals in the U.S., and that number is expected to reach 13 million by 2050.[1] The good news is the Alzheimer's Association says this is a time of great promise in Alzheimer's research with increased government and philanthropic funding and a growing community of scientists — all of which are instrumental to finding new treatments to stop, slow and prevent Alzheimer's disease.[2]

Recommended for you